{
    "Orphapacket": {
        "ORPHApacketId": "842",
        "creationDate": "2022-06-14 15:58:09",
        "version": "1.3.16 / 4.1.7 [2022-01-26] (orientdb version)",
        "copyright": "Orphanet (c) 2022",
        "ORPHAcode": "842",
        "Label": "Testicular seminomatous germ cell tumor",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_842",
        "DisorderType": {
            "value": "Disease",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377788"
        },
        "Synonyms": [
            {
                "Synonym": "Seminoma of testis"
            },
            {
                "Synonym": "Seminomatous germ cell tumor of testis"
            },
            {
                "Synonym": "Testicular seminoma"
            }
        ],
        "ExternalReferences": [
            {
                "Source": "OMIM",
                "Reference": "273300",
                "DisorderMappingRelation": "NTBT (ORPHA code's Narrower Term maps to a Broader Term)"
            }
        ],
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "Testicular seminomatous germ cell tumor is a rare testicular germ cell tumor (see this term) most commonly presenting with a painless mass in the scrotum with a very high cure rate if caught in the early stages."
        },
        "Genes": [
            {
                "Gene": {
                    "Symbol": "KIT",
                    "Name": "KIT proto-oncogene, receptor tyrosine kinase",
                    "ExternalReferences": []
                }
            }
        ],
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "363504",
                        "Label": "Germ cell tumor of testis"
                    }
                ]
            }
        ],
        "Prevalences": [
            {
                "Prevalence": {
                    "Source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "1-9 / 100 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Europe"
                }
            },
            {
                "Prevalence": {
                    "Source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
                    "PrevalenceType": "Lifetime Prevalence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "1-5 / 10 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Europe"
                }
            },
            {
                "Prevalence": {
                    "Source": "ORPHANET",
                    "PrevalenceType": "Point prevalence",
                    "PrevalenceQualification": "Class only",
                    "PrevalenceClass": "Unknown",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Worldwide"
                }
            }
        ],
        "AverageAgeOfOnsets": {
            "AverageAgeOfOnset": [
                {
                    "value": "Adult"
                }
            ]
        },
        "AverageAgeOfDeaths": [
            {
                "AverageAgeOfDeath": {
                    "value": "no data"
                }
            },
            {
                "AverageAgeOfDeath": {
                    "value": "no data"
                }
            }
        ],
        "TypeOfInheritances": {
            "TypeOfInheritance": [
                {
                    "value": "Not applicable"
                }
            ]
        }
    }
}